You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 95 No. 2, FEBRUARY 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  SCIENTIFIC EXHIBITS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

ENDOCRINE THERAPY OF METASTATIC BREAST CANCER

OLOF H. PEARSON, M.D.; CHARLES D. WEST, M.D.; MIN CHIU LI, M.D.; JOHN P. MACLEAN, M.D.; NORMAN TREVES, M.D.

AMA Arch Intern Med. 1955;95(2):357-364.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

VARIOUSe environment which result in therapeutic benefit in patients with metastatic mammary cancer are illustrated. The use of calcium excretion as a practical means of evaluating tumor growth in bone is shown. The results of surgical castration, bilateral adrenalectomy, and hypophysectomy are presented. A physiological basis for these methods of treatment is presented by demonstrating that certain hormones of the ovary, adrenal, and pituitary glands are important in maintaining the growth of mammary cancer. The therapeutic effects of cortisone, estrogens, and androgens are illustrated, with emphasis on the situations in which these hormones are most likely to be of benefit. The sequence of therapeutic measures which is most likely to produce optimum benefit is outlined. . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the Division of Clinical Investigation, Sloan-Kettering Institute for Cancer Research, and the Medical and Breast Services, Memorial and James Ewing Hospitals.


Footnotes

Shown as a scientific exhibit of the Section on Experimental Medicine and Therapeutics at the 103rd Annual Meeting of the American Medical Association, San Francisco, June 21-25, 1954.

These studies were supported in part by grants from the National Cancer Institute, National Institutes of Health, United States Public Health Service, C-925(C6), C-2126; the United States Atomic Energy Commission; the American Cancer Society, Inc., and the Damon Runyon Memorial Fund.

The authors wish to acknowledge the collaboration of Drs. Henry T. Randall, Bronson S. Ray, Willet F. Whitmore, Jr., Charles C. Harrold, Frank E. Adair, George C. Escher, James Green, John Finkbeiner, Joseph Farrow, Guy Robbins, Alfred A. Fracchia, Charles Breed Jr., Dorothy Sved, Richard Kaufman, and Jerome A. Urban.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.